A detailed history of Northwest & Ethical Investments L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 35,277 shares of LLY stock, worth $26.4 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
35,277
Previous 35,277 -0.0%
Holding current value
$26.4 Million
Previous $31.3 Billion -0.0%
% of portfolio
0.83%
Previous 0.83%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $5.52 Million - $6.87 Million
7,154 Added 25.44%
35,277 $31.3 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $20.4 Million - $25.6 Million
28,123 New
28,123 $25.5 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.